Brigham Hyde, CEO of
Precision Health AI, explains the company is building out a data platform for oncology treatment. The firm is building products to serve pharma, life science companies, providers, and payers. In this podcast, Hyde explains how Precision Health AI can help oncologists determine stage of cancer and identify adverse effects. Visit
dhis.net/register to register for the October 11 Digital Healthcare Innovation Summit
Breaking Health